This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morris, A. J. Articles by Reller, L. B. Search for Related Content PubMed PubMed Citation Articles by Morris, A. J. Articles by Reller, L. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Feb 1996, 355-357, Vol 34, No. 2
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Cost and time savings following introduction of rejection criteria for clinical specimens

AJ Morris, LK Smith, S Mirrett and LB Reller
Clinical Microbiology Laboratory, Duke University Medical Center, Durham, North Carolina 27710, USA.

We have evaluated the yield of several tests and have instituted specimen rejection criteria to reduce costs and save time. For a 12- month period, we recorded the reduction of these tests and calculated the resultant cost and time savings. Seven changes were analyzed: not performing fungal or mycobacterial (acid-fast bacillus) cultures on cerebrospinal fluid (CSF) specimens from patients without known immunosuppression when chemistry and cell count are normal; not performing routine stool culture or ovum and parasite examination on specimens from patients in the hospital for > 3 days; not culturing endotracheal suction aspirates when no organisms or > 10 squamous epithelial cells are present; discontinuing broth cultures on all specimens except for tissue, continuous ambulatory peritoneal dialysis fluid, and CSF from patients with shunts; and eliminating bacterial antigen tests. For each test, the number not performed (n), reagent savings, and technologist time saved, respectively, were as follows: CSF fungal culture, 267, $999, and 67 h; CSF acid-fast bacillus culture, 275, $1,662, and 124 h; stool cultures, 320, $2,991, and 98 h; ovum and parasite examinations, 216, $525, and 108 h; endotracheal suction aspirate cultures, 1,505, $4,447, and 306 h; broth cultures, 5,218, $4,931, and 80 h; and bacterial antigen tests, 2,598, $2,293, and 299 h. Overall, 5,181 tests were rejected and 5,218 broth cultures were omitted. Achievable savings were $28,000 in reagent costs and 1,082 h of technologist time. In conclusion, rejecting specimens of proven low yield saves reagent costs and, more importantly, saves technologist time. This time can be spent on specimens having greater diagnostic utility.

This article has been cited by other articles:

• Crump, J. A., Corder, J. R., Henshaw, N. G., Reller, L. B. (2004). Development, Implementation, and Impact of Acceptability Criteria for Serologic Tests for Infectious Diseases. J. Clin. Microbiol. 42: 881-883 [Abstract] [Full Text]  
• Barenfanger, J., Lawhorn, J., Drake, C. (2004). Nonvalue of Culturing Cerebrospinal Fluid for Fungi. J. Clin. Microbiol. 42: 236-238 [Abstract] [Full Text]  
• Lang, A. M., Feris-Iglesias, J., Pena, C., Sanchez, J. F., Stockman, L., Rys, P., Roberts, G. D., Henry, N. K., Persing, D. H., Cockerill, F. R. III (1998). Clinical Evaluation of the Gen-Probe Amplified Direct Test for Detection of Mycobacterium tuberculosis Complex Organisms in Cerebrospinal Fluid. J. Clin. Microbiol. 36: 2191-2194 [Abstract] [Full Text]